Douglas Berger psychiatrist Tokyo has other websites, blogs and social media. And he invites you to visit every one of them.
BLOGS + SOCIAL MEDIA:
INFORMATIONAL PAGE: Douglas-Berger-Psychiatrist-Tokyo-Info.com
REVIEWS WEBSITE: Douglas-Berger-Psychiatrist-Tokyo-Reviews.com
MAIN WEBSITE: DouglasBergerPsychiatristTokyo.com
Counseling Tokyo: to take money from patients for an unproven activity? https://t.co/Hpqw4c2xBN
Tokyo Counseling Service: Catagorizing personality is neither simple nor appropriate. https://t.co/mONoUMDt2X
Douglas Berger Tokyo psychiatrist: brain changes on Mindfulness; subject no and size isn't clear https://t.co/ymXnvrHKzh
Douglas Berger Tokyo psychiatrist: bridge for brain changes seen in mindfulness & efficacy for psychiatric illness https://t.co/K6k7BCrQt4
There is no clear bridge for brain changes seen in mindfulness & efficacy for psychiatric illness: https://t.co/ASq8y9Jzo5. The subjects are all healthy people, making the connection to various psychiatric illness speculation. Us: https://t.co/2cyfo9FRgl
Douglas Berger Tokyo psychiatrist: Brain changes in Mindfulness Based therapy https://t.co/zpuzl9UBif
Douglas Berger Tokyo psychiatrist: Many therapy studies call themselves, “single-blind” https://t.co/uKasdYEwnY
Many therapy studies call themselves, “single-blind”, however, this when the subject is blind, not when assessors are blind. “Single-blind” is misleading the reader that there is some control of bias when there is not. Us: https://t.co/sooQBqR2nb.
Tokyo Counseling Service: Catagorizing Personality, not simple. https://t.co/UhyfW2fHb9 @YouTubeさんから
The no of subjects with brain changes on Mindfulness is not reported: https://t.co/CC4HlhldEi. If only a few subjects had large changes, what does that really say? It is also not clear what the size of this change means clinically or physiologically. Us: https://t.co/WLIjKdXqXL
Brain changes in Mindfulness Based therapy was unblinded with only 16 subjects: https://t.co/CC4HlhldEi. If you look at many brain sections you may find something by chance, you need to half your p value for each section looked at, not done here. Us: https://t.co/kbQF1wSzGN
Tokyo Counseling Service on ADHD https://t.co/LPwy8DzMbB @YouTubeさんから
Antidepressants show efficacy under double blind vs blind placebo because blinding filters out hope and expectation. Neither randomization nor blind assessment can make up for the loss of control from no-blind, no placebo conditions. Us: https://t.co/tReJReVhnP
Blind placebo pills give 30% improvement in depression. In depression drug trials, “non-inferiority” is very easily obtained as everyone responds to the placebo effect. Superiority studies have a higher statistical hurdle than non-inferiority studies. Us: https://t.co/CcbDgs5z45.
Medication vs psychotherapy isn't valid in a clinical trial because you can't double blind all the arms. Its uncontrolled clinical data, endpoints are subjective, and medications require double blinding or blind placebo: https://t.co/WLIjKdXqXL.
Clinical trial of mindfulness therapy (MBT) could be placebo: https://t.co/KNYN1UWrWl. Unblinded study w/no blind placebo. There is no MBT (or CBT, DBT, or other psychotherapy) outcome study that is single or double blind, nor one with a blind placebo. Us: https://t.co/WLIjKdXqXL